Literature DB >> 28302385

Primary cutaneous interdigitating dendritic cell sarcoma is a morphologic and phenotypic simulator of poorly differentiated metastatic melanoma: A report of 2 cases and review of the literature.

Cynthia M Magro1, Luke C Olson1, Gerard Nuovo2, Garron J Solomon3.   

Abstract

Interdigitating dendritic cell sarcoma (IDS) is a rare form of hematologic malignancy associated with an aggressive clinical course. Only 4 prior cases have been described as originating in the skin. We encountered two male patients ages 47 and 61years of age who presented with solitary cutaneous neoplasms diagnosed as IDS. Histologic exam showed a coalescing nested and multinodular proliferation of large pleomorphic epithelioid cells. In one case an initial diagnosis of melanoma was rendered. A recurrence 8months later was then interpreted as a primary cutaneous IDS. This patient died of widespread metastatic disease within 2years from his initial surgery. The other patient has recently undergone wide excision and radiation without any recurrence or metastatic disease during this short follow up time period. Both patients had a tumor exhibiting the same phenotypic profile comprising leukocyte common antigen, SOX10, S100, CD68, and CD163 positivity. In reviewing the 4 other reported cases, there is a similar older male predominance (mean age of 58years) although women affected were significantly younger (mean age of 28years); there was a predilection for the proximal extremities and the face. Patients treated with excision only developed recurrent disease with one patient subsequently dying of metastatic disease. Primary cutaneous IDS is a highly aggressive hematologic malignancy that has many overlapping features with poorly differentiated epithelioid and spindle cell melanoma including SOX10 staining. An aggressive treatment protocol at the beginning could optimize patient survival.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interdigitating dendritic cell sarcoma

Mesh:

Substances:

Year:  2017        PMID: 28302385     DOI: 10.1016/j.anndiagpath.2017.02.008

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  4 in total

1.  A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing.

Authors:  Ki Hwan Hong; Soyoung Song; Wonseok Shin; Keunsoo Kang; Chun-Sung Cho; Yong Tae Hong; Kyudong Han; Jeong Hwan Moon
Journal:  Genes Genomics       Date:  2018-08-11       Impact factor: 1.839

2.  Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Authors:  Fabio Facchetti; Stefano Aldo Pileri; Luisa Lorenzi; Valentina Tabanelli; Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-07-10       Impact factor: 4.064

Review 3.  Interdigitating dendritic cell sarcoma: analysis of two original extra-nodal cases and review of literature.

Authors:  Jiayu Zhou; Qingling Li; Xiaodan Fu; Deyun Feng; Keda Yang; Junpu Wang
Journal:  Virchows Arch       Date:  2022-04-09       Impact factor: 4.064

4.  Interdigitating Dendritic Cell Tumor of Submandibular Lymph Node: Case Report and Literature Review.

Authors:  Soroush Felezi; Anahita Nosrati; Mohammad Eslami Jouybari; Javane Jafarshad
Journal:  Iran J Pathol       Date:  2020-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.